...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Upregulation of cytoplasmic gelsolin, an amyloid-beta-binding protein, under oxidative stress conditions: involvement of protein kinase C.
【24h】

Upregulation of cytoplasmic gelsolin, an amyloid-beta-binding protein, under oxidative stress conditions: involvement of protein kinase C.

机译:在氧化应激条件下细胞质凝溶胶蛋白(一种淀粉样蛋白-β-结合蛋白)的上调:蛋白激酶C的参与。

获取原文
获取原文并翻译 | 示例

摘要

We have previously reported that gelsolin, an actin binding protein, regulates the fibrillization of amyloid-beta protein. We report here that the expression of cytoplasmic gelsolin (cgelsolin) was upregulated in a concentration-dependent manner when SH-SY5Y, PC-12, and HEK-293 cells were subjected to oxidative stress by treatment with hydrogen peroxide (H(2)O(2). Further studies were done to elucidate the mechanism involved in the regulation of c-gelsolin expression in cells. Pretreatment of cells with cycloheximide (an inhibitor of protein synthesis) resulted in significant inhibition of H(2)O(2)induced c-gelsolin expression, suggesting the possible de novo synthesis of c-gelsolin in cells. Staurosporine, a potent inhibitor of a variety of protein kinases including protein kinase C (PKC), also blocked the H(2)O(2)induced expression of cgelsolin. However, both H(2)O(2) and staurosporine activated the mitogen-activated protein kinases (MAPKs), i.e., c-Jun N-terminal kinase, P38, and extracellular signal-regulated kinase. Pretreatment of cells with Calphostin C, an inhibitor of PKC, blocked the upregulation of cgelsolin induced by H(2)O(2), while specific inhibitors of MAPKs had no effect on c-gelsolin expression, suggesting that MAPKs may not be involved in H(2)O(2)mediated upregulation of cgelsolin. On the other hand, phorbol-12-myristate-13-acetate, an activator of PKC, induced the expression of c-gelsolin. Our studies indicate that c-gelsolin is upregulated in cells under oxidative stress, and PKC is involved in its upregulation. It is suggested that activators of PKC that induce gelsolin expression may have therapeutic significance in Alzheimer's disease.
机译:我们以前曾报道过凝溶胶蛋白是一种肌动蛋白结合蛋白,它调节淀粉样β蛋白的原纤维化。我们在这里报告说,当SH-SY5Y,PC-12和HEK-293细胞受到过氧化氢(H(2)O)的氧化应激时,细胞质凝溶胶蛋白(cgelsolin)的表达以浓度依赖性的方式上调。 (2)。进行了进一步的研究以阐明调节细胞中c-凝溶胶蛋白表达的机制。用环己酰亚胺(蛋白质合成抑制剂)预处理细胞会显着抑制诱导的H(2)O(2) c-gelsolin的表达,表明细胞中可能会从头合成c-gelsolin。Staurosporine是多种蛋白激酶(包括蛋白激酶C(PKC))的有效抑制剂,也阻断了H(2)O(2)诱导的表达然而,H(2)O(2)和星形孢菌素均激活了促分裂原激活的蛋白激酶(MAPK),即c-Jun N端激酶,P38和细胞外信号调节激酶。 PKC抑制剂Calphostin C阻止了上调H(2)O(2)诱导的凝溶胶蛋白的合成,而MAPKs的特异性抑制剂对c-凝溶胶蛋白的表达没有影响,这表明MAPKs可能不参与H(2)O(2)介导的凝​​溶胶蛋白的上调。另一方面,佛波醇12-肉豆蔻酸酯13-乙酸酯(一种PKC激活剂)诱导c-凝溶胶蛋白的表达。我们的研究表明c-凝溶胶蛋白在氧化应激下在细胞中被上调,而PKC参与其上调。提示诱导凝溶胶蛋白表达的PKC激活剂在阿尔茨海默氏病中可能具有治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号